Pictet Asset Management (Switzerland)’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $5.19M | Sell |
1,090,260
-108,981
| -9% | -$519K | 0.01% | 766 |
|
|
2023
Q1 | $6.84M | Sell |
1,199,241
-3,114
| -0.3% | -$17.8K | 0.01% | 704 |
|
|
2022
Q4 | $12.1M | Sell |
1,202,355
-947,921
| -44% | -$9.56M | 0.02% | 548 |
|
|
2022
Q3 | $48.2M | Buy |
2,150,276
+48,115
| +2% | +$1.08M | 0.07% | 274 |
|
|
2022
Q2 | $52.1M | Buy |
2,102,161
+743,525
| +55% | +$18.4M | 0.07% | 272 |
|
|
2022
Q1 | $52.7M | Sell |
1,358,636
-52,705
| -4% | -$2.04M | 0.06% | 303 |
|
|
2021
Q4 | $82.6M | Buy |
1,411,341
+456,204
| +48% | +$26.7M | 0.08% | 256 |
|
|
2021
Q3 | $56.6M | Buy |
+955,137
| New | +$56.6M | 0.06% | 313 |
|